Biblio Discovery — Demo Discovery Service

36 hasil untuk "Peng-Chan Lin"

Menampilkan 1–20 · 0,98 detik · RSS

  1. Artikel Jurnal

    Contextualizing Genes by Using Text-Mined Co-Occurrence Features for Cancer Gene Panel Discovery

    Hui-O Chen; Peng-Chan Lin; Chen-Ruei Liu dkk.

    Frontiers in Genetics, Vol. 12 · 2021 · Inggris · DOAJ Scopus

    Developing a biomedical-explainable and validatable text mining pipeline can help in cancer gene panel discovery. We create a pipeline that can contextualize genes by using text-mined co-occurrence features. We apply Biomedical Natural Language Processing (BioNLP) techniques for literature mining…

  2. Artikel Jurnal

    Intratumor Heterogeneity of MYO18A and FBXW7 Variants Impact the Clinical Outcome of Stage III Colorectal Cancer

    Peng-Chan Lin; Yu-Min Yeh; Bo-Wen Lin dkk.

    Frontiers in Oncology, Vol. 10 · 2020 · Inggris · DOAJ Scopus

    Many studies failed to demonstrate benefit from the addition of targeted agents to current standard adjuvant FOLFOX chemotherapy in stage III colorectal cancer (CRC) patients. Intratumor heterogeneity may foster the resistant subclones and leads to cancer recurrence. Here, we built a cancer…

  3. Artikel Jurnal Teks lengkap

    Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan

    Jason C. Hsu; Jia-Yu Lin; May-Ying Hsu dkk.

    PLOS ONE, Vol. 13 No. 8 · 2018 · Inggris · PLOS Scopus

    Background: Since 2012, several immune checkpoint inhibitors have been approved by the Taiwan FDA for various types of cancer treatment. However, none of them are covered by Taiwan National Health Insurance due to the fact that they are expensive, and there is a lack of clinical evidence as to…

    Juga tersedia di: DOAJ

  4. Artikel Jurnal Teks lengkap

    Comprehensive value assessment of drugs using a multi-criteria decision analysis: An example of targeted therapies for metastatic colorectal cancer treatment

    Jason C. Hsu; Jia-Yu Lin; Peng-Chan Lin dkk.

    PLOS ONE, Vol. 14 No. 12 · 2019 · Inggris · PLOS Scopus

    Objective: This study is aimed toward establishing a decision-making model with multiple criteria for appraisal and reimbursement to compare the attitudes of different stakeholders toward various dimensions and criteria and to evaluate the five targeted therapies (bevacizumab, cetuximab…

    Juga tersedia di: DOAJ

  5. Artikel Jurnal

    Combination of Anti-programmed Cell Death Protein 1 and Antiangiogenesis Displaying a Response Disparity between Pulmonary and Nonpulmonary Metastases

    Bing-Syuan Chung; Peng-Chan Lin; Shang-Hung Chen dkk.

    Journal of Cancer Research and Practice, Vol. 10 No. 4 · 2023 · Inggris · DOAJ

    Targeting the vascular endothelial growth factor-mediated immune suppression is a strategy to overcome the resistance of anti-programmed cell death protein 1/programmed death-ligand 1 (anti-PD-1/PD-L1) therapy. Here, we present two cases, including one case with leiomyosarcoma and the other one…

  6. Artikel Jurnal

    Literature-based translation from synthetic lethality screening into therapeutics targets: CD82 is a novel target for KRAS mutation in colon cancer

    Hsih-Te Yang; Ming-Yu Chien; Jung-Hsien Chiang dkk.

    Computational and Structural Biotechnology Journal, Vol. 20 · 2022 · Inggris · DOAJ Scopus

    Synthetic lethality (SL) is an emerging therapeutic paradigm in cancer. We introduced a different approach to prioritize SL gene pairs through literature mining and RAS-mutant high-throughput screening (HTS) data. We matched essential genes from text-mining and mutant genes from the COSMIC and CCLE…

  7. Artikel Jurnal Teks lengkap

    Cutting-Edge AI Technologies Meet Precision Medicine to Improve Cancer Care

    Peng-Chan Lin; Yi-Shan Tsai; Yu-Min Yeh dkk.

    Biomolecules, Vol. 12 No. 8 · 2022 · Inggris · DOAJ Scopus

    To provide precision medicine for better cancer care, researchers must work on clinical patient data, such as electronic medical records, physiological measurements, biochemistry, computerized tomography scans, digital pathology, and the genetic landscape of cancer tissue. To interpret big biodata…

  8. Artikel Jurnal

    Interpretable machine learning approach for optimizing hospice care predictions using health assessment data

    Shih-Yu Cho; Wei-Shu Lai; Jui-Hung Tsai dkk.

    BMC Medical Informatics and Decision Making, Vol. 25 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Background Determining the appropriate end-of-life (EOL) care model within a short time frame is challenging and requires extensive experience. To the best of our knowledge, no studies have developed automatic systems for identifying the hospice care models: hospice home (HHC), inpatient…

  9. Artikel Jurnal

    A novel deep learning-based algorithm combining histopathological features with tissue areas to predict colorectal cancer survival from whole-slide images

    Yan-Jun Li; Hsin-Hung Chou; Peng-Chan Lin dkk.

    Journal of Translational Medicine, Vol. 21 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Background Many methodologies for selecting histopathological images, such as sample image patches or segment histology from regions of interest (ROIs) or whole-slide images (WSIs), have been utilized to develop survival models. With gigapixel WSIs exhibiting diverse histological…

  10. Artikel Jurnal

    A case of acquired hemophilia A and bullous pemphigoid following SARS-CoV-2 mRNA vaccination

    Pei-An Fu; Chien-Wei Chen; Ya-Ting Hsu dkk.

    Journal of the Formosan Medical Association, Vol. 121 No. 9 · 2022 · Inggris · DOAJ Scopus

    Acquired hemophilia is a rare disease resulting from autoantibodies against endogenous factor VIII (FVIII), which associates with bleeding and a high mortality rate. The pathophysiology is still unclear. Recent studies suggest genetic and environmental factors trigger the breakdown of immune…

  11. Artikel Jurnal

    Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer

    Peng-Chan Lin; Yu-Min Yeh; Pei-Ying Wu dkk.

    Scientific Reports, Vol. 10 No. 1 · 2020 · Inggris · DOAJ Scopus

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

  12. Artikel Jurnal

    Controlling the confounding effect of metabolic gene expression to identify actual metabolite targets in microsatellite instability cancers

    Chung-I. Li; Yu-Min Yeh; Yi-Shan Tsai dkk.

    Human Genomics, Vol. 17 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Background The metabolome is the best representation of cancer phenotypes. Gene expression can be considered a confounding covariate affecting metabolite levels. Data integration across metabolomics and genomics to establish the biological relevance of cancer metabolism is challenging…

  13. Artikel Jurnal

    Comprehensive assessments of germline deletion structural variants reveal the association between prognostic MUC4 and CEP72 deletions and immune response gene expression in colorectal cancer patients

    Peng-Chan Lin; Hui-O Chen; Chih-Jung Lee dkk.

    Human Genomics, Vol. 15 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract Background Functional disruptions by large germline genomic structural variants in susceptible genes are known risks for cancer. We used deletion structural variants (DSVs) generated from germline whole-genome sequencing (WGS) and DSV immune-related association tumor microenvironment (TME)…

  14. Artikel Jurnal

    Health inequality: a longitudinal study on geographic variations in lung cancer incidence and mortality in Taiwan

    Jason C. Hsu; Yu-Chi Tseng; Sheng-Mao Chang dkk.

    BMC Public Health, Vol. 20 No. 1 · 2020 · Inggris · DOAJ Scopus

    Abstract Background This study is aimed toward an analysis of the variations in lung cancer incidence and mortality, adjusted by population factors (age, gender, and year), between administrative areas. Methods This is a retrospective study, using 2005–2014 data in each administrative area from the…

  15. Artikel Jurnal

    Lung cancer survival and mortality in Taiwan following the initial launch of targeted therapies: an interrupted time series study

    Jason C Hsu; Chen-Fang Wei; Szu-Chun Yang dkk.

    BMJ Open, Vol. 10 No. 5 · 2020 · Inggris · DOAJ Scopus

    Objectives Two oral targeted therapies, gefitinib and erlotinib, were first approved and then launched into the market for treatment of late-stage non-small cell lung cancer (NSCLC) in Taiwan in 2003 and 2006, respectively. The aim of this study were to determine the trends in lung cancer burden…

  16. Artikel Jurnal

    Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapy

    Peng-Chan Lin; Yu-Min Yeh; Ren-Hao Chan dkk.

    BMC Cancer, Vol. 21 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract Background Certain sequences of genomic mutations can lead to cancer formation and affect treatment outcomes and drug resistance. We constructed a cancer evolutionary tree using bulk-targeted deep sequencing to explore the impact of sequential and co-occurring somatic mutations on patients…

  17. Artikel Jurnal Teks lengkap

    The Expression Quantitative Trait Loci in Immune Response Genes Impact the Characteristics and Survival of Colorectal Cancer

    Ren-Hao Chan; Po-Chuan Chen; Yu-Min Yeh dkk.

    Diagnostics, Vol. 12 No. 2 · 2022 · Inggris · DOAJ Scopus

    The impact of germline variants on the regulation of the expression of tumor microenvironment (TME)-based immune response genes remains unclear. Expression quantitative trait loci (eQTL) provide insight into the effect of downstream target genes (eGenes) regulated by germline-associated variants…

  18. Artikel Jurnal

    The RASAL2 variant promotes aberrant RAS signaling and resistance to anti-EGFR therapy in colorectal cancer

    Yu-Min Yeh; Yi-Hsuan Hsu; Yi-Ting Huang dkk.

    Scientific Reports, Vol. 15 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Anti-EGFR monoclonal antibodies are essential for metastatic colorectal cancer (CRC) treatment, however, resistance remains problematic in KRAS/NRAS/BRAF wild-type patients. RAS protein activator-like 2 (RASAL2) regulates RAS signaling by catalyzing the conversion of RAS. This study…